Modulation of murine neuroblastoma in nude mice by opioid antagonists

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Naltrexone, an opioid antagonist, had an inhibitory effect on the growth of murine S20Y neuroblastoma in BALB/c nude mice. Daily injections of 0.1 mg naltrexone/kg, which invoked a receptor blockade for 6-8 hours/day, resulted in 31-92% delay in latency time prior to tumor expression and a 27-49% increase in mean survival time; the magnitude of antitumor response was governed by tumor burden. Inoculation of neuroblastoma (106-2.5 x 104 cells) resulted in measurable tumors in 10-13 days and mean survival times of 30-34 days. Immunoreactive β-endorphin was detected in tumor tissue (39.7 pg/mg protein). Receptor binding assays revealed specific saturable binding of ligands related to δ- and κ-binding sites, but not for the μ-binding site. These results demonstrate that opioid antagonist modulation of neuro-oncogenesis is not dependent on the integrity of T-cell-mediated immunity and suggest the feasibility of utilizing the nude mouse model in exploring the role of endogenous opioids in human cancers.

Original languageEnglish (US)
Pages (from-to)141-147
Number of pages7
JournalJournal of the National Cancer Institute
Volume78
Issue number1
DOIs
StatePublished - Jan 1 1987

Fingerprint

Narcotic Antagonists
Neuroblastoma
Nude Mice
Naltrexone
Neoplasms
Binding Sites
Endorphins
Tumor Burden
Cellular Immunity
Opioid Analgesics
Carcinogenesis
Ligands
T-Lymphocytes
Injections
Growth
Proteins

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

@article{0f4e1f782f784ae7bbfd5ef97e0a0e1f,
title = "Modulation of murine neuroblastoma in nude mice by opioid antagonists",
abstract = "Naltrexone, an opioid antagonist, had an inhibitory effect on the growth of murine S20Y neuroblastoma in BALB/c nude mice. Daily injections of 0.1 mg naltrexone/kg, which invoked a receptor blockade for 6-8 hours/day, resulted in 31-92{\%} delay in latency time prior to tumor expression and a 27-49{\%} increase in mean survival time; the magnitude of antitumor response was governed by tumor burden. Inoculation of neuroblastoma (106-2.5 x 104 cells) resulted in measurable tumors in 10-13 days and mean survival times of 30-34 days. Immunoreactive β-endorphin was detected in tumor tissue (39.7 pg/mg protein). Receptor binding assays revealed specific saturable binding of ligands related to δ- and κ-binding sites, but not for the μ-binding site. These results demonstrate that opioid antagonist modulation of neuro-oncogenesis is not dependent on the integrity of T-cell-mediated immunity and suggest the feasibility of utilizing the nude mouse model in exploring the role of endogenous opioids in human cancers.",
author = "Ian Zagon and Patricia McLaughlin",
year = "1987",
month = "1",
day = "1",
doi = "10.1093/jnci/78.1.141",
language = "English (US)",
volume = "78",
pages = "141--147",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "1",

}

Modulation of murine neuroblastoma in nude mice by opioid antagonists. / Zagon, Ian; McLaughlin, Patricia.

In: Journal of the National Cancer Institute, Vol. 78, No. 1, 01.01.1987, p. 141-147.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Modulation of murine neuroblastoma in nude mice by opioid antagonists

AU - Zagon, Ian

AU - McLaughlin, Patricia

PY - 1987/1/1

Y1 - 1987/1/1

N2 - Naltrexone, an opioid antagonist, had an inhibitory effect on the growth of murine S20Y neuroblastoma in BALB/c nude mice. Daily injections of 0.1 mg naltrexone/kg, which invoked a receptor blockade for 6-8 hours/day, resulted in 31-92% delay in latency time prior to tumor expression and a 27-49% increase in mean survival time; the magnitude of antitumor response was governed by tumor burden. Inoculation of neuroblastoma (106-2.5 x 104 cells) resulted in measurable tumors in 10-13 days and mean survival times of 30-34 days. Immunoreactive β-endorphin was detected in tumor tissue (39.7 pg/mg protein). Receptor binding assays revealed specific saturable binding of ligands related to δ- and κ-binding sites, but not for the μ-binding site. These results demonstrate that opioid antagonist modulation of neuro-oncogenesis is not dependent on the integrity of T-cell-mediated immunity and suggest the feasibility of utilizing the nude mouse model in exploring the role of endogenous opioids in human cancers.

AB - Naltrexone, an opioid antagonist, had an inhibitory effect on the growth of murine S20Y neuroblastoma in BALB/c nude mice. Daily injections of 0.1 mg naltrexone/kg, which invoked a receptor blockade for 6-8 hours/day, resulted in 31-92% delay in latency time prior to tumor expression and a 27-49% increase in mean survival time; the magnitude of antitumor response was governed by tumor burden. Inoculation of neuroblastoma (106-2.5 x 104 cells) resulted in measurable tumors in 10-13 days and mean survival times of 30-34 days. Immunoreactive β-endorphin was detected in tumor tissue (39.7 pg/mg protein). Receptor binding assays revealed specific saturable binding of ligands related to δ- and κ-binding sites, but not for the μ-binding site. These results demonstrate that opioid antagonist modulation of neuro-oncogenesis is not dependent on the integrity of T-cell-mediated immunity and suggest the feasibility of utilizing the nude mouse model in exploring the role of endogenous opioids in human cancers.

UR - http://www.scopus.com/inward/record.url?scp=0023140866&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023140866&partnerID=8YFLogxK

U2 - 10.1093/jnci/78.1.141

DO - 10.1093/jnci/78.1.141

M3 - Article

C2 - 3025501

AN - SCOPUS:0023140866

VL - 78

SP - 141

EP - 147

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 1

ER -